• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG PROGAV 2.0; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG PROGAV 2.0; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FX424T
Device Problem Mechanical Problem (1384)
Patient Problem Patient Problem/Medical Problem (2688)
Event Date 06/24/2020
Event Type  Injury  
Manufacturer Narrative
When additional information becomes available a follow up report will be submitted.
 
Event Description
In (b)(6) 2015, the product was used for surgery for postmeningitis hydrocephalus in a (b)(6) newborn.Pressure set inside the valve: first time : 7 cm h2o.1 week later : 9 cm h2o.(b)(6) 2016 : 7 cm h2o.(b)(6) 2016 : 5 cm h2o.The patient was discharged because of good progress.(b)(6) 2020 : emergency hospitalization due to sudden changes in condition (headache and vomiting).Shunt failure was not seen on ct images.There was a sign of slit ventricle syndrome, so the setting pressure was changed from 5 cm h2o to 10 cm h2o.(check the changes on the computer, no x-ray).Since there was no improvement after that, a surgeon tried to change the pressure to 15cm h2o on (b)(6), but he could not change the pressure after trying to change it several times.Certas was performed on (b)(6).At last, the patient's conditions improved.After removing the valve, the surgeon tried to change the pressure, but could not confirm the change on the compass.No infection.This is the same patient from notification mdr #- 3004721439-2020-00163 and 3004721439-2020-00161.
 
Manufacturer Narrative
Investigation: visual inspection: the following observations were made during the visual inspection: scratches on the outer housing but no deformations.Deposits on the periphere catheter.Permeability test: the test showed that the progav 2.0 is permeable.Computer control test: the computer controlled test has shown the opening pressure of the progav 2.0, at a reference flow rate of 20 ml/hr in a horizontal position, to be 1.54 cmh2o.This is not within the specified tolerance of 5 cmh2o ± 3 cmh2o.An applied pressure of 5 cmh2o, with the device in the horizontal position is expected to have a resultant opening pressure of 5 cmh2o ± 3 cmh2o.Additional testing did not significantly change the results.According to our results, we can confirm the presence of an overdrainage.Adjustability test: the progav 2.0 was found to be non-adjustable within the specified range.Braking force and brake function test: the braking force test indicates that the brake function of the progav 2.0 is present.Due to the non-adjustability of the valve, an investigation of the braking force was not possible.Internal inspection of product: after dismantling of the valve, clearly deposits were found in progav 2.0.Results: based on our investigation, we are able to substantiate the claim of "over-drainage".We are assuming that the significantly visible deposits within the valve have caused the functional impairment.Deposits caused by natural substances in the cerebrospinal fluid, such as protein, blood or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.From our point of view, no further regulatory actions are required.
 
Event Description
This is the same patient to mdr #3004721439-2020-00163 and 3004721439-2020-00161.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV 2.0
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
ulanenweg 2
potsdam, 14469
GM  14469
MDR Report Key10404833
MDR Text Key207334994
Report Number3004721439-2020-00162
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K141687
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,user f
Type of Report Initial,Followup
Report Date 08/31/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/13/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/10/2020
Device Model NumberFX424T
Device Catalogue NumberFX424T
Device Lot Number20027905
Was Device Available for Evaluation? No
Date Manufacturer Received08/13/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age5 YR
-
-